Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
"Reports Monitor has a new report called" Global Clove leaf oil market Professional Report 2021-2026 ”in its extensive database of research reports. The...